#hematology definition

• Achromatocyte — A pathologically degraded erythrocyte that has completely lost its hemoglobin content, appearing under the microscope as a pale, discolored, or empty cellular structure; a residual red blood cell (erythrocyte ghost) resulting from a severe hemolytic process or mechanical membrane trauma.
• Achromatocyte — A pathological erythrocyte cell form or degraded stage of a red blood cell that has partially or completely lost its normal hemoglobin content, appearing under the microscope as a pale, semitransparent, or fully pigment-depleted cellular structure. This structural phenomenon typically occurs following severe intravascular hemolysis, mechanical cell membrane trauma, or intense osmotic alterations, leaving behind a residual membrane known in specialized literature as an erythrocyte ghost.
• Aleukemia — A particular clinical form of leukemia characterized by the malignant proliferation of hematopoietic tissues, but in which the total number of leukocytes in the peripheral blood remains normal or even decreased, with tumor cells (blasts) being absent or extremely rare in the general circulation, although heavily present in the bone marrow.
• Allochromasia — An alteration or anomaly in the biological coloration of tissues, cells, or organic secretions, characterized by unusual, pathological, or varied hues compared to the normal state. In a strict clinical sense, the term can describe abnormal variations in staining affinity of blood cells during degenerative or infectious processes.
• Aneosinophilia — A severe form of hematological alteration characterized by the total and complete absence of eosinophil granulocytes in peripheral blood, detected through a complete blood count with a differential white blood cell count. This structural clinical phenomenon is frequently associated with the acute stages of severe bacterial infections, septic shock, or as a secondary adverse reaction following prolonged glucocorticoid administration, reflecting a transient collapse of specific immunity.
• Anerythropoiesis — A severe pathological condition characterized by the complete cessation or profound structural failure of the erythropoiesis process (the production and maturation of red blood cells in the bone marrow). This clinical phenomenon halts erythrocyte renewal, leading rapidly to deep or acute aplastic anemia, and is triggered by viral infections (such as parvovirus B19), exposure to myelotoxic agents, or within rare genetic syndromes.
• Angiohemophilia — A complex hereditary hemorrhagic disorder, clinically known as Von Willebrand disease, characterized by the structural association of a capillary vascular anomaly with a qualitative or quantitative deficiency of the Von Willebrand factor and coagulation factor VIII. This pathological syndrome alters the primary hemostasis mechanism, manifesting as prolonged mucosal bleeding, epistaxis, menorrhagia, and spontaneous ecchymoses.
• Anucleated — Lacking a nucleus; refers to cells that do not possess a structural nucleus (either because they lost it during biological maturation, as is the case with adult mammalian erythrocytes, or because they belong to prokaryotic organisms).
• Anucleated — The feminine form of the adjective anucleat; describes a cellular structure, a mature red blood cell, or a living biological formation that lacks a cell nucleus, being structurally optimized to perform specific physiological functions in the organism, such as respiratory gas transport.
• Annulocyte — A pathological red blood cell (erythrocyte) with a ring-like appearance, characterized by an extremely pronounced central pallor and a reduced concentration of hemoglobin restricted to the periphery of the cell membrane; it serves as a specific diagnostic indicator for severe iron-deficiency anemias or thalassemias.